BioBridgeXAll companies

Strand Therapeutics Inc.

Biotechnology company · Boston, Massachusetts, United States

Strand Therapeutics Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2017. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.2 million in total, most recently in 2021. It has reported private securities offerings to the US SEC, most recently $108 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Strand Therapeutics at a glance

Typebiotechnology company
HeadquartersBoston, Massachusetts, United States
Earliest incorporation on record2017
Employees (per SBIR records)8
SEC CIK1778475

What does Strand Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $1.2 million in total (2021). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

3 Form D notices; the most recent reported $108.1 million sold (2026).

Frequently asked questions about Strand Therapeutics

Where is Strand Therapeutics headquartered?

Strand Therapeutics Inc. is headquartered in Boston, Massachusetts, United States.

What does Strand Therapeutics do?

Strand Therapeutics Inc. is a biotechnology company.

When was Strand Therapeutics founded?

The earliest incorporation on record for Strand Therapeutics Inc. is in 2017, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.